本報道最初發表于Endpoints News。請點擊這里查看原文
Early returns suggest that Takeda’s $4 billion immunology bet appears to be paying off.
初步回報顯示,武田(Takeda)制藥斥資40億美元的免疫學押注似乎正在見效。
? The Financial Times Ltd 2025 FT and 'Financial Times' are trademarks of The Financial Times Ltd.